Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors

Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastro...

Full description

Bibliographic Details
Main Authors: Charles Caldwell, James B. Rottman, Will Paces, Elizabeth Bueche, Sofia Reitsma, Joseph Gibb, Vitria Adisetiyo, Michael S. Haas, Heidi Heath, Walter Newman, Jason Baum, Roberto Gianani, Michael H. Kagey
Format: Article
Language:English
Published: Nature Portfolio 2021-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-89060-3
_version_ 1830145080192663552
author Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
author_facet Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
author_sort Charles Caldwell
collection DOAJ
description Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastroesophageal junction (G/GEJ) patients with elevated tumoral expression of DKK1. Here we report on the validation of a DKK1 RNAscope chromogenic in situ hybridization assay to assess DKK1 expression in G/GEJ tumor tissue. To reduce pathologist time, potential pathologist variability from manual scoring and support pathologist decision making, a digital image analysis algorithm that identifies tumor cells and quantifies the DKK1 signal was developed. Following CLIA guidelines the DKK1 RNAscope chromogenic in situ hybridization assay and digital image analysis algorithm were successfully validated for sensitivity, specificity, accuracy, and precision. The DKK1 RNAscope assay in conjunction with the digital image analysis solution is acceptable for prospective screening of G/GEJ adenocarcinoma patients. The work described here will further advance the companion diagnostic development of our DKK1 RNAscope assay and could generally be used as a guide for the validation of RNAscope assays with digital image quantification.
first_indexed 2024-12-17T10:18:05Z
format Article
id doaj.art-386bfb9934384f32ac9a8bd2228acb37
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-17T10:18:05Z
publishDate 2021-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-386bfb9934384f32ac9a8bd2228acb372022-12-21T21:52:52ZengNature PortfolioScientific Reports2045-23222021-05-0111111210.1038/s41598-021-89060-3Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumorsCharles Caldwell0James B. Rottman1Will Paces2Elizabeth Bueche3Sofia Reitsma4Joseph Gibb5Vitria Adisetiyo6Michael S. Haas7Heidi Heath8Walter Newman9Jason Baum10Roberto Gianani11Michael H. Kagey12Flagship BiosciencesAthenaeum Pathology ConsultingFlagship BiosciencesFlagship BiosciencesFlagship BiosciencesFlagship BiosciencesFlagship BiosciencesLeap Therapeutics Inc.Leap Therapeutics Inc.Leap Therapeutics Inc.Leap Therapeutics Inc.Flagship BiosciencesLeap Therapeutics Inc.Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastroesophageal junction (G/GEJ) patients with elevated tumoral expression of DKK1. Here we report on the validation of a DKK1 RNAscope chromogenic in situ hybridization assay to assess DKK1 expression in G/GEJ tumor tissue. To reduce pathologist time, potential pathologist variability from manual scoring and support pathologist decision making, a digital image analysis algorithm that identifies tumor cells and quantifies the DKK1 signal was developed. Following CLIA guidelines the DKK1 RNAscope chromogenic in situ hybridization assay and digital image analysis algorithm were successfully validated for sensitivity, specificity, accuracy, and precision. The DKK1 RNAscope assay in conjunction with the digital image analysis solution is acceptable for prospective screening of G/GEJ adenocarcinoma patients. The work described here will further advance the companion diagnostic development of our DKK1 RNAscope assay and could generally be used as a guide for the validation of RNAscope assays with digital image quantification.https://doi.org/10.1038/s41598-021-89060-3
spellingShingle Charles Caldwell
James B. Rottman
Will Paces
Elizabeth Bueche
Sofia Reitsma
Joseph Gibb
Vitria Adisetiyo
Michael S. Haas
Heidi Heath
Walter Newman
Jason Baum
Roberto Gianani
Michael H. Kagey
Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
Scientific Reports
title Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_full Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_fullStr Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_full_unstemmed Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_short Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
title_sort validation of a dkk1 rnascope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors
url https://doi.org/10.1038/s41598-021-89060-3
work_keys_str_mv AT charlescaldwell validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT jamesbrottman validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT willpaces validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT elizabethbueche validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT sofiareitsma validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT josephgibb validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT vitriaadisetiyo validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT michaelshaas validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT heidiheath validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT walternewman validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT jasonbaum validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT robertogianani validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors
AT michaelhkagey validationofadkk1rnascopechromogenicinsituhybridizationassayforgastricandgastroesophagealjunctionadenocarcinomatumors